These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3096110)
1. Pharmacokinetics of lopamidol after intrathecal administration in humans. Duchin KL; Drayer BP; Ross M; Allen S; Frantz M AJNR Am J Neuroradiol; 1986; 7(5):895-8. PubMed ID: 3096110 [TBL] [Abstract][Full Text] [Related]
2. Rate of clearance of intrathecal iopamidol in the dog. Wilcox J; Evill CA; Sage MR Neuroradiology; 1986; 28(4):359-61. PubMed ID: 3762917 [TBL] [Abstract][Full Text] [Related]
3. Seizure after intrathecal administration of iopamidol. Lipman JC; Wang AM; Brooks ML; Schick RM; Rumbaugh CL AJNR Am J Neuroradiol; 1988; 9(4):787-8. PubMed ID: 3135723 [No Abstract] [Full Text] [Related]
4. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography. Sahani DV; Soulez G; Chen KM; Lepanto L; Xu JR; Nelson RC; Grazioli L; Vanzulli A; Heiken JP; Invest Radiol; 2007 Dec; 42(12):856-61. PubMed ID: 18007158 [TBL] [Abstract][Full Text] [Related]
5. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872 [TBL] [Abstract][Full Text] [Related]
6. Clinical experience with iomeprol in myelography and myelo-CT: clinical pharmacology and double-blind comparisons with iopamidol, iohexol, and iotrolan. Katayama H; Heneine N; van Gessel R; Taroni P; Spinazzi A Invest Radiol; 2001 Jan; 36(1):22-32. PubMed ID: 11176258 [TBL] [Abstract][Full Text] [Related]
7. Iopamidol for intrathecal use in pediatric neuroradiology. Ruggiero R; Piscitelli G; Ambrosio A Acta Radiol Suppl; 1986; 369():532-6. PubMed ID: 2980550 [TBL] [Abstract][Full Text] [Related]
8. [Side effects and contrast medium resorption of iopamidol and iocarmate in lumbar myelography]. Stoeter P; Bergleiter R; Schneider I; Kubina FG Computertomographie; 1982 Dec; 2(4):179-83. PubMed ID: 6821243 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effect of low- and iso-osmolar contrast agents on heart rate during chest CT angiography: results of a prospective randomized multicenter study. Chartrand-Lefebvre C; White CS; Bhalla S; Mayo-Smith WW; Prenovault J; Vydareny KH; Soto JA; Ozkan OS; Chughtai AR; Soulez G Radiology; 2011 Mar; 258(3):930-7. PubMed ID: 21212367 [TBL] [Abstract][Full Text] [Related]
10. CT-determined canine kidney and urine iodine concentration following intravenous administration of sodium diatrizoate, metrizamide, iopamidol, and sodium ioxaglate. Brennan RE; Rapoport S; Weinberg I; Pollack HM; Curtis JA Invest Radiol; 1982; 17(1):95-100. PubMed ID: 7076442 [TBL] [Abstract][Full Text] [Related]
11. Intrathecal administration of iopamidol in children: clinical and diagnostic results. Wells RG; Seidel FG; Sty JR; Swick HM Pediatr Radiol; 1988; 18(3):190-3. PubMed ID: 3368243 [TBL] [Abstract][Full Text] [Related]
13. Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study. Velázquez MT; Albarrán A; Hernández F; García Tejada J; Zueco J; Andreu J; De la Torre JM; Figueroa A; Sainz F; Tascón J Acta Cardiol; 2010 Aug; 65(4):387-94. PubMed ID: 20821930 [TBL] [Abstract][Full Text] [Related]
14. Comparison of intravenous contrast agents for CT studies in children. Cohen MD; Herman E; Herron D; White SJ; Smith JA Acta Radiol; 1992 Nov; 33(6):592-5. PubMed ID: 1449887 [TBL] [Abstract][Full Text] [Related]
15. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography. Breglia A; Godi I; Virzì GM; Guglielmetti G; Iannucci G; De Cal M; Brocca A; Carta M; Giavarina D; Ankawi G; Passannante A; Yun X; Biolo G; Ronco C Cardiorenal Med; 2020; 10(2):125-136. PubMed ID: 32036364 [TBL] [Abstract][Full Text] [Related]
16. [-Cervical myelography using the lumbar route-]. Parlier-Cuau C; Wybier M; Moutounet L; Champsaur P; Laredo JD Ann Radiol (Paris); 1997; 40(2):99-103. PubMed ID: 9754339 [TBL] [Abstract][Full Text] [Related]
17. Lumbar myelography with iopamidol: a methodological approach to the investigation of side effects. Provinciali L; Signorino M; Giovagnoli AR; Baroni M; Angeleri F; Salvolini U; Pasquini U; Porta M; Judice A; Cerutti R Neuroradiology; 1988; 30(6):528-33. PubMed ID: 3226540 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological and cognitive effects of lumbar myelography with iopamidol: comparison with diagnostic lumbar puncture. Provinciali L; Ceravolo MG; Signorino M; Baroni M; Pasquini U; Cerrutti R; Salvolini U Neuroradiology; 1993; 35(7):483-6. PubMed ID: 8232868 [TBL] [Abstract][Full Text] [Related]
19. An experimental evaluation of response to contrast media: Pantopaque, iopamidol, and iohexol in the subarachnoid space. Paşaoğlu A; Gök A; Patiroğlu TE Invest Radiol; 1988 Oct; 23(10):762-6. PubMed ID: 3192397 [TBL] [Abstract][Full Text] [Related]
20. Iotrol, a new myelographic agent: 1. Radiography, CT, CSF clearance, and brain penetration. Kerber CW; Sovak M; Ranganathan RS; Heilman CB AJNR Am J Neuroradiol; 1983; 4(3):317-8. PubMed ID: 6410732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]